Terms: = Colorectal cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Diagnosis
3 results:
1. cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.
Giordano G; Febbraro A; Tomaselli E; Sarnicola ML; Parcesepe P; Parente D; Forte N; Fabozzi A; Remo A; Bonetti A; Manfrin E; Ghasemi S; Ceccarelli M; Cerulo L; Bazzoni F; Pancione M
J Exp Clin Cancer Res; 2015 Oct; 34():108. PubMed ID: 26427914
[TBL] [Abstract] [Full Text] [Related]
2. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays.
Barderas R; Babel I; Díaz-Uriarte R; Moreno V; Suárez A; Bonilla F; Villar-Vázquez R; Capellá G; Casal JI
J Proteomics; 2012 Aug; 75(15):4647-55. PubMed ID: 22465712
[TBL] [Abstract] [Full Text] [Related]
3. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
[TBL] [Abstract] [Full Text] [Related]
